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Antigenic determinants encoded by genes of the HLA-D region have been related 
to at least three separate molecular complexes, DR, MB (also known as DC and LB- 
E), and SB. At the cell surface each complex has a  dimeric structure composed of a 
structurally conserved a-chain noncovalently associated with a polymorphic fl-chain. 
The DR  and MB series of determinants have been extensively characterized using 
allospecific serological reagents and, to date,  10 DR and 3 MB allotypes are recog- 
nized. Beyond these serologically detectable polymorphisms, HLA-D region products 
exhibit an  additional  degree of antigenic complexity revealed by cellular reagents 
such as homozygous typing cells (HTC). These cells respond to antigenic determinants 
(Dw/LD determinants)  that  are  phenotypically distinct  from those  recognized by 
available antisera. Thus, within a panel of individuals of a single serologically defined 
DR  type, such as DR4, a  number of different Dw/LD specificities including Dw4, 
Dwl0, DYT, DB3, and LD40 exist (1). 
In this report we have addressed this cellularly detected antigenic complexity from 
a  molecular perspective. Using  isoelectric focusing (IEF)  to analyze DR  molecules 
immunoprecipitated from a panel of individuals homozygous for DR4, but expressing 
different Dw/LD determinants, we have observed that  (a)  between DR4 fl-chains, 
but not a-chains, considerable structural polymorphism exists and (b) the particular 
DR fl-chain structural  configuration observed upon  IEF is associated with the cell 
Dw/LD type. These data, thus, provide the first molecular evidence associating the 
Dw/LD determinants recognized by cellular reagents to the serologically defined DR 
molecule. 
Materials and Methods 
Identification and Derivation of DR4 Lymphoblastoid Cell Lines.  DR and Dw/LD typing was 
performed according to previously described  methods (2, 3). Whole blood was obtained from 
healthy DR4, Dw/LD homozygous donors. After centrifugation on a Ficoll-Hypaque cushion, 
lymphocytes were macrophage depleted by plastic  adherence and B cell enriched by rosette- 
depleting T cells with AET-treated sheep erythrocytes (4). LCL were established  by infecting 
the B cell-enriched lymphocyte population with  Epstein-Barr virus  according to published 
procedures (5). LCL were maintained with RPMI  1640 containing 25 mM Hepes buffer and 
10% heat-inactivated fetal bovine serum. 
Cell Labeling, Immunoprecipitation, and  Two-dimensional Gel Analysis.  LCL were  cell-surface- 
labeled by lactoperoxidase-catalyzed 125I-iodination and membrane proteins detergent-solubi- 
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lized as described previously (6).  DR  complexes were isolated from  the detergent lysates by 
immunoprecipitation with a purified HLA-DR monoclonal antibody, clone L243  (7)  (Becton, 
Dickinson  &  Co.,  Mountain  View,  CA)  utilizing Staphylococcus  aureus  Cowan  strain  I  as  an 
immunoabsorbent (8). Immunoprecipitated DR molecules were separated into a- and/?-chain 
component  by sodium  dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The 
appropriate molecular weight regions of the first dimensional gel were identified with fluores- 
ceinated or dansylated molecular weight markers and areas containing the DR a- and/?-chains 
were excised. Flat-bed IEF was  performed essentially as described by Shackelford et  al.  (9). 
Samples were cast directly into the IEF gel and sealed in place by polymerizing the gel onto the 
hydrophilic surface of a  GelBond PAG film (FMC Corp., Rockland, ME).  LKB ampholines 
(LKB, Bromma, Sweden) and the mixtures used are detailed in the legend to Fig. 2. Focusing 
was carried out at 600 V  for 1 h  and  1,100 V  for 7 h. After IEF the gel was fixed, dried, and 
autoradiographed using Cronex II (DuPont Instruments, Wilmington, DE) intensifying screens 
and Kodak XAR-5 film at -70°C. 
Results 
Fig.  1 is an SDS-PAGE analysis of molecules immunoprecipitated by the anti-DR 
antibody, L243,  from  detergent  lysates of four DR4  t~I-labeled LCL that  represent 
four different Dw/LD  phenotypes. The L243 antibody used for immunoprecipitation 
in this study has been well characterized and is known to react with a  monomorphic 
DR  determinant  (7).  Furthermore,  this  antibody does  not  appear  to  recognize MB 
products, and, in  most cases, the reactivity includes all known subsets of mature cell 
surface  DR  molecules  (9-12).  From  each  cell lysate a  typical DR  a-fl-chain dimer 
with molecular weights of ~34,000 and 28,000, respectively, was immunoprecipitated. 
Of note is the finding that  the DR fi-chain from the DR4/Dwl0  LCL reproducibly 
migrates slower than  the DR fl-chain immunoprecipitated from  DR4  LCL of other 
Dw/LD  types (Fig. 1, see asterisk). This has been confirmed with another DR4/Dwl0 
LCL  (data not shown)  and suggests that  the DR4 fi-chain associated with the Dwl0 
phenotype may be larger, or has a  different molecular configuration, than  the DR4 
fl-chains associated with other Dw/LD  types. 
IEF  patterns  of  DR4  /?-chains,  isolated  from  the  first  dimension  SDS  gels,  are 
shown in Fig. 2. In our analyses, all DR4 fl-chains, regardless of Dw/LD  type, focused 
F~o.  1.  SDS-PAGE migration patterns of DR4 fl-chains from Dw/LD disparate LCL DR4 chains 
were  immunoprecipitated from lysates of 12SI-labeled  Dw/LD  disparate LCL  and  analyzed  as 
described in Materials and Methods. In our hands, DR4 a-chains consistently labeled less intensely 
than the corresponding/j-chains using the lactoperoxidase 12'5I procedure. The reduced mobility of 
the DR4/J-chains associated with the Dwl0 phenotype  (see asterisk) was confirmed with another 
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FXG. 2.  IEF analysis of DR4 fl-chains from Dw/LD disparate LCLs. DR4 fl-chains were isolated 
from the first dimension SDS-PAGE and focused as described in Materials and Methods. (A) Minor 
DR bands are denoted with arrowheads. Bracketed spots originated from traces of DR4 a-chain 
present in the first dimension gel slice. Samples were polymerized at the anode and a mixture of pH 
3.5-10, 4-6 and 6-8 (1:0.25:0.25) ampholines were used. Conditions of analysis were identical in (B) 
except that the pH 6-8 ampholine was replaced by pH 3.5-5 ampholine. 
as a  cluster of three major bands and one or more considerably less intensely labeled 
bands.  These  minor  bands  were  frequently  not  visible  under  the  autoradiographic 
development conditions as used for the data presented  in Fig. 2. Although the extent 
of this  DR  fl-chain  microheterogeneity  was  essentially  identical  between  Dw/LD 
disparate  LCL, considerable  differences  were  observed  in  the  equilibrium  focusing 
positions of the DR fl-chain band clusters.  Thus, while the DR fl-chains of the three 
DI~4/Dw4 LCL examined (two are shown in Fig. 2 A) showed IEF patterns that were 
indistinguishable,  the DR fl-chains from the two DR4/Dwl0  LCL, while identical to 
one another (Fig. 2 B), exhibited markedly more acidic equilibrium  focusing positions 
(Fig. 2 A). Furthermore,  the DR4/DYT  fl-chain cluster is reproducibly more basic as 
compared to the DR4 fl-chains from Dw4,  LD-40, and  Dwl0  LCLs  (Fig.  2A).  The 
DR fl-chain cluster of the DR4/LD40 LCL migrated in a manner apparently identical 
to the DR fl-chains from the DR4/Dw4  LCL in several experiments.  Neither the use 
of ampholine  mixtures  tailored  to provide expanded  pH  ranges  nor combining DR 
immunoprecipitates  from  DR4/Dw4  and  DR4/LD40  LCL could  discriminate  be- 
tween  these  two  populations  of DR  fl-chains  (data  not  shown).  The  DR  a-chains 
from the  Dw/LD  disparate  LCL were  indistinguishable  from one another  by both 
one and two dimensional  gel analyses for all the LCL studied  (data not shown). 
Discussion 
Studies  to  date  have  indicated  that  the  fl-chain  of  the  DR  complex  is  both 
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different DR allotypes exhibit  different IEF characteristics  (13-15).  However, struc- 
tural  polyrnorphism  between  DR  fl-chains  isolated  from  cells  carrying  the  same 
serologically defined DR specificity has not been previously described.  Our present 
study provides firm evidence in this regard: not only is there a minor difference in the 
migration of the DR fl-chains from DR4/Dwl0  LCL detectable  in  first dimension 
SDS-PAGE, but there are at least three different groups of IEF patterns detectable in 
the DR fl-chains isolated from the seven DR4 LCL examined in this study. There is, 
thus,  clear  polymorphism of the  DR4  fl-chains  that  can  be  demonstrated  at  the 
molecular level but that is not detected with the currently available alloantisera. 
We recognize that  DR4,  as currently  defined serologically, may in  the future be 
"split." This does not  detract  from the central  focus of these studies,  which  was to 
determine  whether  a  molecular  corollary  for  the  Dw/LD  polymorphism  detected 
among DR4 cells by cellular reagents exists within the DR4 fl-chain populations. No 
conclusions have, in  the past, been possible regarding the molecular relationship  of 
DR and Dw/LD specificities despite their close association in population and family 
studies  (16).  However, recent studies using mutants of the LCL line, 721  (17,  and R. 
DeMars, C. Chang, and R. Rudersdorf, manuscript in preparation), in combination 
with "cloned" primed lymphocyte typing (PLT) reagents (18), have suggested a close 
genetic association between DR and Dw/LD (19). 
The findings  presented  above provide evidence that  variation in  the structure of 
the DR4 fl-chain correlates with at least three different Dw/LD phenotypes. Although 
our IEF analyses could  not  distinguish  between  the DR4 fl-chains from LD40  and 
Dw4 LCLs, these data do not rule out differences between these molecules. Structural 
modification of DR fl-chains sufficient to cause conformational changes and, hence, 
presentation  of a  modified  antigenic  profile  may not  necessarily  result  in  overall 
charge changes. For example, altered complexity of carbohydrate moieties occurring 
without  concomitant  changes  in  the number of terminal  sialic  acid  residues would 
not be detected by these IEF procedures. 
Summary 
The  results  of this  study  demonstrate  the  existence  of molecular  heterogeneity 
(polymorphism) within DR fl-chains isolated from a  single serologically defined DR 
phenotype, DR4. The data are consistent with the possibility that this polymorphism 
is related to the Dw/LD phenotype as defined with the cellular reagents, homozygous 
typing cells. 
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